WS #6563
The dominant signal in this window is a significant escalation in the Iran-US conflict in the Strait of Hormuz, with multiple sources corroborating new Iranian missile and drone attacks on the UAE, and the US establishing a military presence. This marks a clear escalation from the previous ceasefire narrative. Oil futures initially fell but pared losses on the news, while the US ISM Services PMI came in slightly below forecast at 53.6. Separately, several notable earnings reports and corporate actions provide stock-specific signals: Harley-Davidson missed EPS estimates due to a $45M tariff hit, Pfizer beat but with mixed quality, and Cytokinetics rallied on positive trial data. The macro narrative is shifting from a stable ceasefire to renewed geopolitical risk, which is likely to support energy stocks and weigh on consumer discretionary and airlines.
Key developments
- Iran launches new missile and drone attacks on UAE; US establishes military presence in Strait of Hormuz
- Harley-Davidson Q1 EPS misses estimates on $45M tariff hit
- Pfizer Q1 beats estimates but quality mixed; FY guide held
- Cytokinetics stock rallies after Phase 3 heart disease study hits dual primary endpoints
- US ISM Services PMI slightly below forecast at 53.6